US Archives - Page 58 of 112 - European Medical Journal

Cardiovascular Imaging Breakthroughs for Rheumatic Disease

A recent study evaluated the advantages and limitations of various noninvasive imaging modalities in diagnosing cardiovascular disease (CVD) in patients with autoimmune rheumatic diseases (ARDs).

Future of AI in Aesthetic Skin Care

Recent advancements in artificial intelligence (AI) are reshaping dermatology, particularly in diagnosing skin diseases like skin cancer.

Perinatal Lead Exposure Linked to Lower Vaccine Antibody Response

Emerging research highlights critical windows of susceptibility to lead exposure that may reduce antibody responses to childhood vaccines, raising concerns for immune health.

AI Tool Using Blood Tests Predicts Cancer Immunotherapy Success

A machine learning model, SCORPIO, has shown promise in predicting the success of immune checkpoint inhibitors (ICIs) for patients with cancer.

Semaglutide Cuts Alcohol Cravings in New Trial

A new randomized clinical trial suggests that once-weekly semaglutide may help reduce alcohol consumption and cravings in adults with alcohol use disorder (AUD).

NIH Funding Cuts Threaten U.S. Health

The National Institutes of Health (NIH) faces substantial funding cuts that could derail progress in critical medical research.

Glucose-Lowering Drugs Lower COPD Exacerbations

Sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) may significantly reduce the risk of chronic obstructive pulmonary disease (COPD) exacerbations in patients with type 2 diabetes (T2D), according to a large U.S.-based study.

Antibacterial Activity of Apple Cider Vinegar Against Multidrug-Resistance

Antibiotic-resistant Escherichia coli and Klebsiella pneumoniae are major causes of urinary tract infections (UTIs) and vaginal inflammation, posing a growing health challenge worldwide.

Blood Transplant Survivors Face Skin Cancer Risks

Survivors of blood or marrow transplants (BMT) face a significantly higher risk of developing cutaneous malignant neoplasms, including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma, according to a recent cohort study.

Abemaciclib-Induced ILD Risk Explored

A recent prospective cohort study highlights the incidence and clinical course of abemaciclib-induced interstitial lung disease (ILD) in patients with hormone receptor-positive (HR+), HER2-negative metastatic breast cancer (MBC) previously treated with chemotherapy.